RecruitingPhase 3NCT07133308
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Intervention
- Deuruxolitinib(drug)
- Enrollment
- 355 target
- Eligibility
- 12-17 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- Total Skin And Beauty Dermatology Center, Birmingham, Alabama, United States
- Avacare - Cct Research - Center For Dermatology And Plastic Surgery, Scottsdale, Arizona, United States
- Dermatology Trial Associates, Bryant, Arkansas, United States
- Kern Research Inc., Bakersfield, California, United States
- Center For Dermatology Clinical Research Inc., Fremont, California, United States
- Dermatology Research Associates, Los Angeles, California, United States
- Palmtree Clinical Research, Palm Springs, California, United States
- Paradigm Clinical Research - San Diego, San Diego, California, United States
- Colorado Medical Research Center, Denver, Colorado, United States
- Paradigm Clinical Research - Wheat Ridge, Wheat Ridge, Colorado, United States
- D&H Doral Research Center, Doral, Florida, United States
- Skin Care Research, Llc - Hollywood, Hollywood, Florida, United States
- Ilumina Medical Research Llc, Kissimmee, Florida, United States
- All X Ray Diagnostic Services Corp, Miami, Florida, United States
- Millennium Medical Research Llc, Miami, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07133308 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC